21.4
Allarity Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
4.97
FY23:
1.97
FY24:
22.3
FY25:
17.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
28.2
FY22:
9.58
FY23:
9.89
FY24:
0.31
FY25:
0.33
Total assets
Change from FY21 to FY25
millions USD
FY21:
49.6
FY22:
14.5
FY23:
11.9
FY24:
22.7
FY25:
18.3
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
20.7
FY22:
11.2
FY23:
14.2
FY24:
10.8
FY25:
8.43
(negative)
Change from FY21 to FY25
millions USD
FY21:
10.1
FY22:
1.43
FY23:
0.45
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
18.2
FY22:
−0.11
FY23:
−2.75
FY24:
11.8
FY25:
9.83
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
49.0
FY22:
–
FY23:
11.9
FY24:
22.7
FY25:
18.3
All amounts in millions USD